Metrion Biosciences was formed in September 2015, following a management buyout of Xention Limited’s contract research business. The Metrion team has substantial experience of providing high quality drug discovery services for ion channel targets to clients on a fee-for-service or collaboration basis. Metrion is also a leading provider of cardiac safety profiling, cardiac translational assays and neuronal translational assa...
Metrion Biosciences was formed in September 2015, following a management buyout of Xention Limited’s contract research business. The Metrion team has substantial experience of providing high quality drug discovery services for ion channel targets to clients on a fee-for-service or collaboration basis. Metrion is also a leading provider of cardiac safety profiling, cardiac translational assays and neuronal translational assays.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.